Twenty-eight suicide-related events were reported.
. The conclusion of the 2008 review was that the available data did not indicate that the risk of NPAEs in influenza patients was increased by exposure to oseltamivir, and that there was no obvious mechanism by which oseltamivir or its active metabolite could cause or worsen such events.
The purpose of the current article is to update the 2008 review, by reporting additional information generated since the first article was written. For ease of comparison, this update occurring in children ≤16 years ( Table 1 ). The proportion attributable to children was somewhat lower than that reported in the original review (72.7%). However, the difference in distribution by country compared with the original review is substantial: Japanese patients accounted for 42 .5% of all events in the current analysis, a much smaller proportion than previously (Japan accounted for 90.9% of NPAEs in the first review).
In the current analysis, patients from the USA and (4) 52 (5) 65 (8) 23 (7) 42 (9) Delusions/perceptual disturbance 316 (18) 121 (17) 195 (18) 164 (20) 70 (20) 94 (19) Depressed level of consciousness 32 (2) 17 (2) 15 (1) 15 (2) 12 (3) 3 (1) Encephalitis 27 (1) 10 (1) 17 (2) 27 (3) 10 (3) 17 (3) Loss of consciousness 37 (2) 29 (4) 8 (1) 19 (2) 15 (4) 4 (1) Miscellaneous psychiatric 370 (20) 191 (26) 179 (17) 107 (13) 50 (14) 57 ( MedDRA terms and associated preferred terms in three classes (nervous system disorders, psychiatric disorders, and accidents/injuries) are grouped into 13 categories prescriptions (Table 2) fell markedly in Japan, from 127 to 55, whereas in the ROW, the rate rose more than twofold (210; original review, 92).
In the USA, the rate fell slightly from 27 to 25. (Table 3) . However, the association of delirium and delirium-like symptoms with NPAE categories in children was different to that in adults. In children, they were most commonly associated with abnormal behavior (39%); delusions and perceptual disturbances accounted for 20% and miscellaneous psychiatric events for 18% of these symptoms. In adults, however, the strongest association was with miscellaneous psychiatric events (32%; Table 3 ).
Accidents and Injuries
All reports of accidents and injuries in the safety database were reviewed, whether or not they were associated with NPAEs. Twentyseven events were reported in 23 individuals (seven events in six children); 18 events in 15 individuals were serious; one of these events happened 6 days after the onset of pyrexia.
Suicide-Related Events
The original review reported incidence of suicide-related events in patients exposed to
oseltamivir. 
NPAEs IN PROSPECTIVE CLINICAL TRIALS OF OSELTAMIVIR
The original review included a summary of NPAEs 
NPAEs IN RETROSPECTIVE SURVEILLANCE STUDIES
In The results of the first study, on patients ≥1 year old in the UH database [7] , were reported in the 2008 review [1] , as they had been presented at a scientific meeting in 2007. In summary, that study found a significantly lower incidence of NPAEs in the oseltamivir cohort than the no-antiviral cohort, a difference that applied to analyses of all events, major events, and events specific to CNS disorders. In patients ≤17 years old, incidence rates in the two cohorts (n = 20,250 and 80,900 respectively) were not significantly different [7] .
A new study, not analyzed in the first review, was undertaken in children and adolescents (aged 1-21 years) with an influenza diagnosis, using data from the US Department of Defense's TRICARE database, which contains healthcare information on over 9 million beneficiaries [8] .
The incidence of all NPAEs was significantly lower in the oseltamivir cohort (n = 7,798) than the no-antiviral cohort (n = 10,411), with rates of 3.0% and 3.8% respectively (P < 0.05).
Unlike the two analyses described above, groups
were not matched for propensity scores, but a logistic regression analysis that adjusted for this factor found a significantly lower risk of events Other researchers subsequently criticized the reallocation of patients from the treated to the untreated groups in this study: the re-calculation by Yorifuji et al. [10] 26.2%; P = 0.13). The most common event (13/22 and 13/18, respectively) was recorded as "irritable", which suggests a mood disorder rather than a neurological one; two seizures occurred, one in each group [12] .
REPORTS OF NPAEs IN INFLUENZA PATIENTS AND RELATIONSHIP TO OSELTAMIVIR TREATMENT
In the 2008 review, five reports from Japan and Taiwan on influenza patients aged ≤18 years indicated that NPAEs occurring in influenza patients were similar whether or not they are exposed to oseltamivir, and that many events occur before treatment initiation [1] . Since then, a paper by Hama [13] was published that presents details of adverse events in eight Japanese patients who were prescribed oseltamivir, the events typically being of sudden onset. The events resulted in five deaths, three during sleep, and two from accidents associated with abnormal behavior. All these cases are recorded in the Roche safety database, and review of the cases found no conclusive evidence that oseltamivir had caused the NPAEs or the deaths. after oseltamivir treatment were similar to those whose symptoms preceded treatment [15] . In another Japanese study of 11 children who had delirious behavior within 3 days of the onset of influenza, seven had received no antiviral therapy, two patients had received oseltamivir, and two had received zanamivir, which is poorly bioavailable systemically [16] .
The literature search identified case reports or case series describing NPAEs in 62 influenza patients exposed to oseltamivir -the most common events were seizures, encephalitis, and altered consciousness, and were mainly reported in children and adolescents. For 10 of these patients, the timing of oseltamivir treatment relative to the development of the events was not clearly described; eight of 10 patients recovered without sequelae [17] [18] [19] [20] .
Of 52 patients in whom the timing of oseltamivir administration relative to the NPAE was documented, most (38) slowing on day 5 of oseltamivir treatment and who improved rapidly after treatment had stopped [34] .
The third case was a 17-year-old, who had a generalized seizure after two doses of oseltamivir and who recovered with no further seizures; he completed a 5-day course of oseltamivir [43] . [68] . The younger group in the latter study also had a higher incidence of hepatic dysfunction (notably mild elevation of aspartate aminotransferase levels), more lowdensity areas on brain computed tomography scans and significantly more sequelae [68] .
Marked elevations of aspartate aminotransferase (≥500 IU/mL) were one of four variables that significantly increased mortality risk in children aged <15 years with IAE, others being hyperglycemia, blood or protein in the urine, and diclofenac use [69] .
In the studies mentioned above, most or all of the patients were infected with influenza A virus infections, which reflects the relative prevalence of type A and type B viruses. Two reports from
Taiwan focused solely on CNS events in young patients with influenza B infections. In the larger study, a survey of 314 patients, 13 (4.1%) patients (mean age 5.3 years) had encephalitis or encephalopathy, one of whom died [57] , and in the other study, one of 87 patients aged <18 years (1.1%) had encephalitis [70] . Influenza B infection was also diagnosed in a 14-year-old Japanese boy who injured himself falling from a window after symptoms of parasomnia, fever, and fatigue [71] .
A single case of acute encephalopathy associated with influenza C infection was also reported, in a 2-year-old Japanese boy, although the outcome was not described [72] .
Children with more severe influenza complications, in particular ANE, continue to be the subject of case reports and series. ANE can have other etiologies, and a retrospective report of 22 Japanese children with ANE found that 11 (50%) influenza-associated cases had similar pathology to 11 (50%) noninfluenza-associated cases, although brain stem lesions were more common in the former group [73] . Outcomes in this study were also similar, with four and three deaths (36% and 27%), respectively. The high morbidity and mortality rate in ANE is reflected in nine single case reports in children and adolescents aged 2-12 years old: the condition was fatal in four children, and caused severe disablement in two of five who survived [29, 32, 33, 36, 38, [74] [75] [76] [77] . An inherited susceptibility to ANE has been discovered, characterized by a mutation in the RAN binding protein 2 gene [78] , and the clinical presentation of two patients thus affected has recently been reported [74] . Another case report documented a 3-year-old girl with marked neurological impairment resulting from IAE combined with cerebral vasculopathy and edema characteristic of posterior reversible encephalopathy syndrome [79] .
Adults
In contrast to the experience in Asian countries, a survey of hospitalized influenza patients in Sweden found that those affected by encephalitis were mainly middle-aged men, although cases were rare (21 in 11.5 years) [53] . Adults also 
PHARMACOKINETIC PROFILE OF OSELTAMIVIR IN THE CNS

CNS Exposure to Oseltamivir and its
Metabolite in Animals
The original review summarized data, mostly from animal studies, that show penetration of both oseltamivir and its carboxylate metabolite into the CNS to be very low [1] , and the results of our nonclinical studies on CNS pharmacokinetics have since been published separately [83] .
Additional data have since been reported from a pharmacokinetic study in adult mice, which mapped the distribution of radiolabelled oseltamivir and oseltamivir carboxylate after intravenous injection. This study found that the ratio of concentrations for brain-to-plasma were 0.07-0.14 and 0.06-0.13, respectively [84] .
These results are in general agreement with those of preclinical studies that employed a variety of methods [83] , and somewhat higher than the cerebrospinal fluid (CSF)-to-plasma ratios of 0.02-0.03 found in healthy volunteers [85] .
Regulation of Oseltamivir and Oseltamivir
Carboxylate Levels in the CNS
The influence of a range of transport systems These data suggest that, in this case, animal data may have limited relevance to humans.
In another recently reported pharmacokinetic study, mice with lipopolysaccharide (LPS)-induced inflammation, which increases the permeability of the BBB, had brain concentrations of oseltamivir and oseltamivir carboxylate that were 2 and 2.7-times those in control mice [88] .
These limited increases in brain concentrations
in the presence of LPS-induced inflammation are regarded as clinically irrelevant, as there are very large safety margins [83, 89] .
PHARMACODYNAMIC PROFILE IN THE CNS
Animal Studies
Some recent publications suggest that oseltamivir may have a stimulant effect in the CNS. One study by a US group reported that oseltamivir carboxylate facilitated neuronal firing in ex vivo rat hippocampal slices [90] ;
however, in a well-controlled study that used a similar protocol, the authors were not able to replicate this finding [91] . A second study, by a Japanese group, reported that oseltamivir carboxylate enhanced neuronal synchronization in pyramidal cells from the rat hippocampus ex vivo [92] . Interpretation of observed abnormal behavior in rodent hippocampal models is not straightforward, as they were initially developed to study learning and epilepsy. The reported excitatory properties of oseltamivir in these models contrast with the findings of pharmacology studies that showed no binding of oseltamivir carboxylate to a large variety of host targets including dopaminergic and glutamatergic targets [89, 93] .
In addition, in vivo animal studies have failed to show excitatory effects of oseltamivir and its metabolite either in a proconvulsive rodent model, on modulation of hexobarbitalinduced sleeping in rodents, or on hyperactivity in rodents, even at very high doses [94] .
The study described above, which showed neuro-excitatory properties of oseltamivir carboxylate in rat models, also reported enhancement of this effect by ethanol [90] .
Oseltamivir carboxylate and ethanol also produced hypothermia and altered behavior (e.g., changes in righting reflex, although the authors acknowledged that the latter were difficult to interpret). In addition, synaptic transmission in hippocampal slices was shown to be facilitated by a combination of oseltamivir carboxylate, ephedrine, and caffeine [95] .
The use of ethanol and stimulants in these studies was prompted by the observation that Japanese influenza patients sometimes take these agents in combination with oseltamivir.
However, the doses of ethanol used in the first rodent study (3.3 g/kg in vivo; 60 mmol/L ex vivo) were excessively high and would be highly toxic or even fatal in humans. Similarly, the concentrations of oseltamivir and its metabolite used were much higher than extrapolated therapeutic concentrations [89] . The reports in the Roche safety database did not indicate any concomitant intake of ethanol or ethanolcontaining products (e.g., cough syrups) in children experiencing NPAEs.
Effect on Sleep Parameters
To investigate the effect of oseltamivir on sleep, a placebo-controlled polysomnography study was conducted in 31 healthy Japanese adults using a crossover design. Sleep parameters and EEGs were assessed for four consecutive nights, with oseltamivir being given on the 3rd and 4th days (75 mg single evening dose on day 3; two 75 mg doses [morning and evening] on day 4).
Compared with placebo, the study showed no clinically relevant effect on EEGs, on sleep parameters, or on normal sleep behavior [96] .
GENETIC INFLUENCES
As mentioned above, oseltamivir is hydrolyzed in the body by human carboxylesterases (HCEs) to the active metabolite oseltamivir carboxylate [97, 98] .
The specific enzyme responsible for the hydrolysis is HCE1, found principally in the liver [99] . (sTNF-R1) were similar in the three groups [56] .
Cytokine elevation was also noted in case reports of acute encephalopathy and ANE [30, 72, 76] , and elevation of IL-6 was shown to mirror abnormal EEG changes in influenzainfected rats with induced hyperthermia [107] .
Other workers have shown that LPS- accompanied by EEG abnormalities [16, 116] or raised cytokine levels [46] , and may result in mild CNS disorders in some younger patients [117] [118] [119] . A 14-year-old boy treated with the inhaled topical agent zanamivir had neurological symptoms, such as dysarthria and dysphagia, associated with a reversible splenial lesion 5 days after influenza onset [119] . A speech disorder in a boy with influenza and a splenial lesion was attributed by the authors to dysarthria of nonneurological origin [120] . [127, 128] . In patients with IAE, who expressed variants of carnitine palmitoyltransferase II, energy metabolism in mitochondria was impaired, which could contribute to brain edema via increased BBB permeability [128] . These findings are in line with previous reports that carnitine metabolism was impaired in many patients with severe IAE [129] , and that serum concentrations of the mitochondrial protein cytochrome C can predict the severity of encephalopathy [130] .
Another metabolic mechanism that could be linked to CNS damage is the presence of organic acidemias, inherited metabolic disorders, which were found in a small proportion of children with IAE [131] . Reports from recently published literature on influenza patients who had CNS complications and received oseltamivir, show that in the majority of cases, the adverse events happened or developed before drug administration, and were not exacerbated by subsequent administration.
Mild encephalopathy was also reported in a patient treated with zanamivir, which is not absorbed systemically to significant levels [119] .
In nine cases where events happened or worsened after oseltamivir treatment, six were not considered to be drug-related, and NPAEs in the other three included symptoms such as seizures and EEG slowing, which are known to be associated with influenza infection itself, as described earlier.
In the authors' analysis of accidents and showing lack of interaction with relevant CNS targets [89, 93] , lack of interference with sleep in humans [96] , and lack of excitatory effects in animals [94] suggest there would be no functional implications of such changes.
As reviewed above, more evidence has been 
